FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approved a supplemental application for Norditropin (somatropin) by Novo Nordisk under BLA021148. The action pertains to changes approved as part of the Nor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Prader-willi Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• Norditropin (somatropin)

Snippet

SUPPL AP for NORDITROPIN (SOMATROPIN)